135 related articles for article (PubMed ID: 37059243)
1. Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus.
Subramaniam S; Joyce P; Prestidge CA
Int J Pharm; 2023 May; 639():122927. PubMed ID: 37059243
[TBL] [Abstract][Full Text] [Related]
2. Liquid Crystal Nanoparticles Enhance Tobramycin Efficacy in a Murine Model of
Thorn CR; Wignall A; Kopecki Z; Kral A; Prestidge CA; Thomas N
ACS Infect Dis; 2022 Apr; 8(4):841-854. PubMed ID: 35255215
[TBL] [Abstract][Full Text] [Related]
3. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus.
Radlinski L; Rowe SE; Kartchner LB; Maile R; Cairns BA; Vitko NP; Gode CJ; Lachiewicz AM; Wolfgang MC; Conlon BP
PLoS Biol; 2017 Nov; 15(11):e2003981. PubMed ID: 29176757
[TBL] [Abstract][Full Text] [Related]
5. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
[TBL] [Abstract][Full Text] [Related]
6. Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms.
Thorn CR; Carvalho-Wodarz CS; Horstmann JC; Lehr CM; Prestidge CA; Thomas N
Small; 2021 Jun; 17(24):e2100531. PubMed ID: 33978317
[TBL] [Abstract][Full Text] [Related]
7. Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections.
Thorn CR; Kopecki Z; Wignall A; Kral A; Prestidge CA; Thomas N
Nanomedicine; 2022 Jun; 42():102536. PubMed ID: 35202839
[TBL] [Abstract][Full Text] [Related]
8.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
9. Potent antibacterial nanoparticles for pathogenic bacteria.
Lai HZ; Chen WY; Wu CY; Chen YC
ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
11. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria.
Beaulac C; Sachetelli S; Lagace J
J Antimicrob Chemother; 1998 Jan; 41(1):35-41. PubMed ID: 9511035
[TBL] [Abstract][Full Text] [Related]
12. Novel Chimeric Endolysin Conjugated Chitosan Nanocomplex as a Potential Inhibitor Against Gram-Positive and Gram-Negative Bacteria.
Abbasi P; Fahimi H; Khaleghi S
Appl Biochem Biotechnol; 2024 Jan; 196(1):478-490. PubMed ID: 37140784
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of bacterial DNA synthesis during postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
[TBL] [Abstract][Full Text] [Related]
15. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
17. Protective Liquid Crystal Nanoparticles for Targeted Delivery of PslG: A Biofilm Dispersing Enzyme.
Thorn CR; Raju D; Lacdao I; Gilbert S; Sivarajah P; Howell PL; Prestidge CA; Thomas N
ACS Infect Dis; 2021 Aug; 7(8):2102-2115. PubMed ID: 33908759
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions.
Boulanger S; Mitchell G; Bouarab K; Marsault É; Cantin A; Frost EH; Déziel E; Malouin F
Antimicrob Agents Chemother; 2015 Dec; 59(12):7458-64. PubMed ID: 26392496
[TBL] [Abstract][Full Text] [Related]
19. Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells.
Pashizeh F; Mansouri A; Bazzazan S; Abdihaji M; Khaleghian M; Bazzazan S; Rezei N; Eskandari A; Mashayekhi F; Heydari M; Tavakkoli Yaraki M
Int J Biol Macromol; 2024 Feb; 258(Pt 2):128957. PubMed ID: 38154726
[TBL] [Abstract][Full Text] [Related]
20. Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.
Bose RJC; Tharmalingam N; Choi Y; Madheswaran T; Paulmurugan R; McCarthy JR; Lee SH; Park H
Int J Nanomedicine; 2020; 15():8437-8449. PubMed ID: 33162754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
